Research paper · methodology foundation

A causal, multi-institution framework for tracing the effects of U.S. government decisions

GII: A Causal, Multi-Institution Framework for Tracing the Effects of United States Government Decisions.

Kurt Sather · v1.1.1 · 2026-07-19 · Proprietary — all rights reserved

The research paper states the measurement problem — five related gaps: institutional fragmentation, decision-to-outcome fragmentation, forecast-versus-observation confusion, aggregation without distribution, and false certainty — and grounds the GII-US answer in the potential-outcomes framework, modern staggered-treatment econometrics, composite-indicator practice, federal evidence standards, and legal measurement research.

Download DOCXDownload PDFCite this work

Primary research question#

How can the material, institutional, legal, social, and economic effects of United States government decisions be measured over time and traced to their decision origins without collapsing uncertainty, distribution, and qualitatively different outcomes into a misleading single judgment?

Research propositions under test#

#Proposition
1Lineage: cross-institution policy lineages explain observed effects more accurately than isolated document attribution.
2Heterogeneity: national means materially understate variation across households, geographies, public bodies, nonprofits, industries, and firm sizes.
3Forecast calibration: divergence between forecast and observed impact varies systematically by decision type, domain, and evidence maturity.
4Implementation: legal effectiveness alone is an incomplete proxy for realized exposure and impact.
5Measurement: a magnitude–direction–confidence scorecard is more stable and interpretable than a single positive/negative composite.
6Revision: data vintages and legal-status changes materially affect a nontrivial share of early estimates.
These are falsifiable commitments, tested in the 2015–2025 historical pilot with preregistered case selection, named inter-rater statistics, backtesting, placebo and negative-control outcomes, and adversarial review from methodologists with different policy perspectives.